LegitScript certification and Google's Restricted Health Advertiser program explained for peptide brands, what they check, who needs it, and how it affects your ability to run ads.
If a peptide brand's Google Ads account gets flagged for unauthorised healthcare advertising even though the ad copy looks compliant, the missing piece is often certification, not creative. Google increasingly requires advertisers in restricted health categories to prove who they are and what they sell before it lets their ads run at all, regardless of how carefully the copy is written. LegitScript is the verification body Google leans on to make that call for pharmacy, supplement, and adjacent healthcare categories.
LegitScript is a third-party monitoring and certification service that reviews businesses in regulated categories, including online pharmacies, CBD, dietary supplements, and increasingly peptides and research chemicals, against legal, safety, and advertising-policy standards. Google, Bing, and several payment processors use LegitScript certification, or LegitScript's underlying monitoring data, as part of how they decide which advertisers in these categories are allowed to run healthcare-adjacent campaigns.
Certification isn't a rubber stamp. LegitScript reviews business registration, product claims, website content, and in some categories manufacturing and sourcing documentation, before issuing a certification mark that Google's ad review systems can recognise.
Peptides sit in a genuine grey zone. They are not FDA-approved drugs for most applications, they are commonly sold as research-use-only products, and yet many buyers use them for outcomes that look a lot like healthcare claims. Google's automated and human review systems increasingly treat this grey zone the same way they treat other unregulated healthcare products: by asking for third-party verification rather than trying to adjudicate every individual ad.
This shows up in practice as Google's Restricted Drug Terms Certification requirement, introduced for advertisers using personalised targeting involving pharmaceutical terms in the US, Canada, and New Zealand. Brands running personalised or remarketing campaigns that reference peptide compound names may need this certification specifically to keep those campaigns eligible for full targeting capability, separate from general ad approval.
| Situation | Certification Likely Needed |
| Running Search ads with compound names as keywords, no personalised targeting | Usually not required, but strengthens account trust signals |
| Running remarketing or personalised audience campaigns referencing pharmaceutical terms | Likely required under Restricted Drug Terms Certification |
| Account has a history of policy strikes or disapprovals in this category | Strongly recommended as part of a recovery and prevention plan |
| Scaling into markets with stricter healthcare ad enforcement | Recommended proactively, before expansion rather than after a suspension |
Because ongoing monitoring is part of the deal, certification also raises the bar internally: product claims and landing pages need to stay compliant on an ongoing basis, not just at the point of certification.
Getting certified doesn't mean every ad automatically passes review. Compliant account architecture, negative keyword strategy, and landing page alignment still matter just as much after certification as before. What certification changes is the baseline trust signal Google's systems assign to your account, which reduces false-positive disapprovals and gives you a stronger position if you do need to appeal a policy decision.
We've covered the account-level compliance side of this in depth in our Google Ads Policy for Peptide Brands guide, and the account-structure side in our case study on scaling a peptide brand to $260K/month with zero policy flags.
If your peptide brand is running or planning personalised targeting campaigns referencing compound names, or has a history of policy friction, LegitScript certification and Google's Restricted Drug Terms Certification are worth pursuing proactively rather than reactively. They won't replace compliant ad copy and account structure, but they remove one of the most common reasons legitimate, well-run accounts still get caught in automated healthcare-category enforcement.
We'll review your current targeting setup and tell you honestly whether certification would help your account, and what the process would involve for your specific product line.
Or email directly: sveta@oney.studio
Oney Studio is a specialist Google Ads agency for peptide and research chemical brands. We build compliance-first account architecture that scales, from cold start to six-figure monthly revenue, without account-level policy flags.
Get a free 30-minute audit of your Google Ads or Meta Ads account. We’ll review compliance, structure, and growth opportunities — no strings attached.
Book a Free Audit